According to Cosmo Pharmaceuticals's latest financial reports the company has $0.24 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.25 B | 2.54% |
2021-12-31 | $0.25 B | -3.88% |
2020-12-31 | $0.26 B | -12.86% |
2019-12-31 | $0.30 B | -24.84% |
2018-12-31 | $0.39 B | 92.81% |
2017-12-31 | $0.20 B | 18.3% |
2016-12-31 | $0.17 B | 37.78% |
2015-12-31 | $0.12 B | 75.89% |
2014-12-31 | $72.32 M | -68.86% |
2013-12-31 | $0.23 B | 543.05% |
2012-12-31 | $36.11 M | 104.53% |
2011-12-31 | $17.65 M | -53.34% |
2010-12-31 | $37.84 M | 52.69% |
2009-12-31 | $24.78 M | -20.01% |
2008-12-31 | $30.98 M | -16.79% |
2007-12-31 | $37.24 M | 1104.44% |
2006-12-31 | $3.09 M | 283.09% |
2005-12-31 | $0.8 M | 117.15% |
2004-12-31 | $0.37 M |